Prudential Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.8M Buy
145,330
+26,030
+22% +$3.19M 0.02% 444
2025
Q1
$13.5M Sell
119,300
-90,875
-43% -$10.3M 0.02% 483
2024
Q4
$25.1M Buy
210,175
+33,450
+19% +$4M 0.03% 332
2024
Q3
$20.4M Sell
176,725
-17,529
-9% -$2.02M 0.03% 449
2024
Q2
$26.7M Buy
194,254
+78,136
+67% +$10.8M 0.04% 340
2024
Q1
$16M Sell
116,118
-213,253
-65% -$29.4M 0.02% 508
2023
Q4
$43.4M Buy
329,371
+50,204
+18% +$6.61M 0.07% 251
2023
Q3
$31.5M Buy
279,167
+193,117
+224% +$21.8M 0.05% 328
2023
Q2
$8.11M Buy
86,050
+21,980
+34% +$2.07M 0.01% 723
2023
Q1
$6.4M Buy
64,070
+9,193
+17% +$919K 0.01% 796
2022
Q4
$6.55M Buy
54,877
+5,227
+11% +$624K 0.01% 767
2022
Q3
$5.15M Buy
49,650
+19,991
+67% +$2.07M 0.01% 876
2022
Q2
$2.91M Sell
29,659
-31,192
-51% -$3.06M ﹤0.01% 1184
2022
Q1
$5.71M Buy
60,851
+38,962
+178% +$3.65M 0.01% 919
2021
Q4
$2.03M Buy
21,889
+4,096
+23% +$380K ﹤0.01% 1528
2021
Q3
$1.72M Sell
17,793
-5,530
-24% -$534K ﹤0.01% 1538
2021
Q2
$2.27M Sell
23,323
-15,208
-39% -$1.48M ﹤0.01% 1414
2021
Q1
$3.75M Sell
38,531
-28,016
-42% -$2.72M 0.01% 1154
2020
Q4
$6.38M Sell
66,547
-13,556
-17% -$1.3M 0.01% 909
2020
Q3
$7.7M Sell
80,103
-11,527
-13% -$1.11M 0.01% 769
2020
Q2
$11.2M Buy
91,630
+35,573
+63% +$4.34M 0.02% 660
2020
Q1
$4.85M Buy
56,057
+10,613
+23% +$919K 0.01% 931
2019
Q4
$4.89M Buy
45,444
+1,170
+3% +$126K 0.01% 1138
2019
Q3
$3.99M Buy
44,274
+34,752
+365% +$3.13M 0.01% 1225
2019
Q2
$804K Sell
9,522
-4,202
-31% -$355K ﹤0.01% 1948
2019
Q1
$1.21M Sell
13,724
-12,749
-48% -$1.12M ﹤0.01% 1806
2018
Q4
$1.89M Buy
26,473
+13
+0% +$928 ﹤0.01% 1538
2018
Q3
$3.25M Buy
26,460
+21,890
+479% +$2.69M ﹤0.01% 1391
2018
Q2
$449K Hold
4,570
﹤0.01% 2078
2018
Q1
$379K Hold
4,570
﹤0.01% 2082
2017
Q4
$355K Sell
4,570
-700
-13% -$54.4K ﹤0.01% 2102
2017
Q3
$323K Hold
5,270
﹤0.01% 2123
2017
Q2
$242K Sell
5,270
-172,200
-97% -$7.91M ﹤0.01% 2212
2017
Q1
$7.68M Sell
177,470
-62,700
-26% -$2.71M 0.01% 955
2016
Q4
$9.3M Buy
240,170
+8,357
+4% +$323K 0.01% 882
2016
Q3
$11.7M Sell
231,813
-32,850
-12% -$1.66M 0.02% 771
2016
Q2
$12M Sell
264,663
-522
-0.2% -$23.7K 0.02% 751
2016
Q1
$10.5M Buy
265,185
+177,088
+201% +$7M 0.02% 791
2015
Q4
$4.98M Hold
88,097
0.01% 1074
2015
Q3
$3.51M Buy
88,097
+170
+0.2% +$6.76K 0.01% 1192
2015
Q2
$4.2M Hold
87,927
0.01% 1191
2015
Q1
$3.49M Buy
87,927
+200
+0.2% +$7.94K 0.01% 1315
2014
Q4
$1.96M Sell
87,727
-900
-1% -$20.1K ﹤0.01% 1476
2014
Q3
$1.39M Sell
88,627
-8,477
-9% -$133K ﹤0.01% 1600
2014
Q2
$1.44M Buy
97,104
+8,377
+9% +$124K ﹤0.01% 1673
2014
Q1
$1.43M Buy
88,727
+400
+0.5% +$6.44K ﹤0.01% 1630
2013
Q4
$825K Sell
88,327
-300
-0.3% -$2.8K ﹤0.01% 1821
2013
Q3
$1M Sell
88,627
-38,600
-30% -$437K ﹤0.01% 1735
2013
Q2
$1.7M Buy
+127,227
New +$1.7M ﹤0.01% 1466